Semaglutide (20 mg) Dosing & Observed Effects in Research The following information summarizes published research protocols and clinical development data and is provided strictly for scientific context
Biological Activity Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM)
If your vial does not clearly state the concentration in mg/mL, do not inject from it
It works by increasing insulin release, lowering the amount of glucagon released, delaying gastric emptying, and reducing appetite
In the GLORY-1 and GLORY-2 trials, mazdutide produced beneficial effects on every prespecified cardiometabolic measure
Shipping costs for the two smaller tiers aren't listed on the main product page - confirm the total at checkout before finalizing your order